Trulicity®
Dulaglutide · GLP-1 Injection
Once-weekly ready-to-use GLP-1 pen — simple, steady appetite and blood-sugar support.
Trulicity® (dulaglutide) is a once-weekly injection by Eli Lilly. It mimics the natural GLP-1 hormone, reducing appetite and improving blood-sugar regulation. Its single-use, auto-injector pen is pre-set and ready to use — a gentler option for patients who find manual pens intimidating. Licensed in the UK for type 2 diabetes; weight reduction is a common co-benefit.
- Active ingredient
- Dulaglutide
- Format
- Single-use auto-injector pen
- Frequency
- Once weekly
- Prescription
- Required
Benefits
Why patients choose Trulicity®.
Once weekly
Same day each week — a sustainable, low-effort dosing schedule.
Ready-to-use auto-injector
Pre-set dose, hidden needle — easier for needle-nervous patients.
Cardiometabolic support
Shown to reduce cardiovascular events in patients with type 2 diabetes.
UK clinician-reviewed
Every prescription is assessed for safety and suitability before dispatch.
How it works
A simple, evidence-based approach.
- 1
Inject once a week — same day each week, at any time, with or without food.
- 2
Dulaglutide activates GLP-1 receptors that regulate appetite and insulin response.
- 3
Start at 0.75 mg weekly, stepping up to 1.5 mg, 3 mg or 4.5 mg as tolerated.
- 4
Pairs well with a healthier eating pattern and physical activity.
Choose your dose
Prescription-only medicine. Every order is reviewed by a UK-registered prescriber before dispatch.
Questions
Trulicity® FAQs
Everything you need to know before starting your course.
Alternatives
